A case with life-threatening interstitial pneumonia associated with bucillamine treatment
Tóm tắt
We report a case of bucillamine-induced interstitial pneumonia accompanied by severe hypoxemia in an 83-year-old woman who had rheumatoid arthritis. Respiratory failure worsened even after withdrawal of bucillamine and administration of high-dose corticosteroids, and mechanical ventilation was required. A review of 15 cases with bucillamine-induced pulmonary injury suggests that advanced age may be associated with the development of severe interstitial pneumonia. Bucillamine can cause corticosteroid-resistant and life-threatening lung injury, especially in the elderly.
Tài liệu tham khảo
Sekiguchi N, Kameda H, Amano K, Takeuchi T. Efficacy and safety of bucillamine, a D-penicillamine analogue, in patients with rheumatoid arthritis. Mod Rheumatol. 2006;16:85–91.
Hara A, Sakamoto O, Matsumoto M, et al. A case of bucillamine-induced interstitial pneumonia. Nihon Kyobu Shikkan Gakkai Zasshi. 1992;30:1743–8 (in Japanese).
Tanaka H, Nakahara K, Goto K. A case of bucillamine-induced pneumonitis. Nihon Kyobu Shikkan Gakkai Zasshi. 1992;30:695–701 (in Japanese).
Inokuma S, Sakata M, Yoshida A, Shiratori K, Kiyosawa H. Bucillamine induced pulmonary injury occurs with immunoglobulin decrease. J Rheumatol. 1996;23:1282–5.
Fukino K, Shiota T, Nakaya Y, et al. A case of drug-induced interstitial pneumonitis in rheumatoid arthritis treated with bucillamone. Bronchology. 1997;19:232–6 (in Japanese).
Lee YH, Kim YR, Ji JD, et al. A case of BOOP developed during bucillamine treatment for rheumatoid. Korean J Intern Med. 2001;16:36–9.
Matsushima H, Takayanagi N, Sakamoto T, et al. A case of drug-induced interstitial pneumonitis in rheumatoid arthritis treated with bucillamine. Nihon Kokyuki Gakkai Zasshi. 2001;39(1):55–9 (in Japanese).
Miwa Y, Kaga S, Hanaoka R, et al. A case of rheumatoid arthritis complicated with a pneumonitis during concomitant treatment with methotrexate and bucillamine. Ryumachi. 2002;42:70–5 (in Japanese).
Kishimoto N, Fujii K. A case of pulmonary infiltration with eosinophilia (PIE) syndrome induced by bucillamine treatment of rheumatoid arthritis. Nihon Kokyuki Gakkai Zasshi. 2002;40:321–5 (in Japanese).
Tanimura K, Shimizu M, Matsuhashi M, Shinohara M, Sagawa A. A case of interstitial pneumonia caused by bucillamine: a study using serological markers. Mod Rheumatol. 2006;16:39–43.
Nanke Y, Yamada T, Kamatani N. Asymptomatic interstitial pneumonitis induced by bucillamine in a patient with rheumatoid arthritis. Mod Rheumatol. 2005;15:381–2.
Kajiya T, Kuroda A, Hokonohara D, Tei C. Radiographic appearance of bronchiolitis obliterans organizing pneumonia (BOOP) developing during Bucillamine treatment for rheumatoid arthritis. Am J Med Sci. 2006;332:39–42.
Saito Y, Nei T, Abe S, et al. A case of bucillamine-induced interstitial pneumonia with positive lymphocyte stimulation test for bucillamine using bronchoalveolar lavage lymphocytes. Intern Med. 2007;46:1739–43.
Arnett FC, Edworthy SM, Bloch DA, et al. The American rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988;31:315–24.
Brown KK. Rheumatoid lung disease. Proc Am Thorac Soc. 2007;4:443–8.
Negishi M, Kaga S, Kasama T, et al. Lung injury associated with bucillamine therapy. Ryumachi. 1992;32:135–9 (in Japanese).
Kurashima K, Nakao S, Fujimura M, Matsuda T. Bucillamine-induced hypersensitivity pneumonitis. Chest. 1992;101:1479–80.
Battaglia S, Sandrini MC, Catalano F, et al. Effects of aging on sensation of dyspnea and health-related quality of life in elderly asthmatics. Aging Clin Exp Res. 2005;17:287–92.